Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Sales | 2,318 | 5,014 | 481 | 83 | 0 |
| Cost of Goods | 1,879 | 1,659 | 15 | N/A | N/A |
| Gross Profit | 439 | 3,355 | 466 | 83 | N/A |
| Operating Expenses | 8,949 | 8,259 | 6,467 | 7,888 | 0 |
| Operating Income | -7,631 | -4,245 | -5,986 | -7,805 | N/A |
| Interest Expense | 3,303 | 2,180 | 110 | 125 | 0 |
| Other Income | -230 | 176 | 74 | 26 | 0 |
| Pre-tax Income | -11,164 | -6,249 | -6,022 | -7,904 | 0 |
| Net Income Continuous | -11,164 | -6,249 | -6,022 | -7,904 | N/A |
| Net Income | $-11,164 | $-6,249 | $-6,022 | $-7,904 | $N/A |
| EPS Basic Total Ops | -2.23 | -1.43 | -2.26 | -3.93 | N/A |
| EPS Basic Continuous Ops | -2.24 | -1.43 | -2.26 | -3.93 | N/A |
| EPS Diluted Total Ops | -2.23 | -1.43 | -2.26 | -3.93 | N/A |
| EPS Diluted Continuous Ops | -2.24 | -1.43 | -2.26 | -3.93 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.29 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,092 | $-3,903 | $-5,683 | $-7,560 | $N/A |